tiprankstipranks
Edwards Lifesciences (EW)
NYSE:EW

Edwards Lifesciences (EW) Income Statement

1,635 Followers

Edwards Lifesciences Income Statement

Last quarter (Q4 2023), Edwards Lifesciences's total revenue was $1.53B, an increase of 13.78% from the same quarter last year. In Q4, Edwards Lifesciences's net income was $369.90M. See Edwards Lifesciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 6.00B$ 6.00B$ 5.38B$ 5.23B$ 4.39B$ 4.35B
Cost of Revenue
$ 1.38B$ 1.38B$ 1.08B$ 1.25B$ 1.08B$ 1.11B
Gross Profit
$ 4.63B$ 4.63B$ 4.30B$ 3.98B$ 3.31B$ 3.23B
Operating Expense
$ 2.69B$ 2.69B$ 2.51B$ 2.40B$ 1.99B$ 1.99B
Operating Income
$ 1.70B$ 1.53B$ 1.79B$ 1.59B$ 1.32B$ 1.24B
Net Non Operating Interest Income Expense
$ 41.00M$ 49.60M$ 16.30M$ -1.00M$ 7.60M$ 11.50M
Other Income Expense
$ -40.60M$ -40.60M$ -38.40M$ -136.80M$ -407.50M$ -83.70M
Pretax Income
$ 1.60B$ 1.60B$ 1.77B$ 1.70B$ 916.70M$ 1.17B
Tax Provision
$ 198.70M$ 198.70M$ 245.50M$ 198.90M$ 93.30M$ 119.60M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ 1.40B$ 1.81B$ 1.52B$ 1.50B$ 823.40M$ 1.05B
Basic EPS
$ 2.31$ 2.31$ 2.46$ 2.41$ 1.32$ 1.68
Diluted EPS
$ 2.30$ 2.30$ 2.44$ 2.38$ 1.30$ 1.64
Basic Average Shares
$ 2.43B$ 606.70M$ 619.00M$ 623.30M$ 622.60M$ 624.90M
Diluted Average Shares
$ 2.44B$ 609.40M$ 624.20M$ 631.20M$ 631.90M$ 636.60M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
----$ 1.86$ 1.86
Rent Expense Supplemental
------
Total Expenses
$ 4.07B$ 4.07B$ 3.59B$ 3.65B$ 3.07B$ 3.11B
Net Income From Continuing And Discontinued Operation
$ 1.40B$ 1.40B$ 1.52B$ 1.50B$ 823.40M$ 1.05B
Normalized Income
$ 894.40M$ 1.25B--$ 1.19B$ 1.12B
Interest Expense
----$ 15.80M$ 20.70M
EBIT
$ 1.60B$ 1.60B$ 1.79B$ 1.70B$ 932.50M$ 1.19B
EBITDA
$ 1.78B$ 1.77B$ 1.95B$ 1.86B$ 1.04B$ 1.28B
Currency in USD

Edwards Lifesciences Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis